Infectious Disease Doctors in West Palm Beach, FL Accepting Medicare

7 Infectious Disease doctors found. Showing 1 - 7

James Bruce Morris, M.D. Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 10338 Orchid Reserve Dr, West Palm Beach, FL 33412 Phone: 561-630-8788

Thomas Anthony Parrino, M.D Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 7305 N. Military Trail, Chief Of Staff's Office (11), West Palm Beach, FL 33410 Phone: 561-422-8603    Fax: 561-422-8613

Dr. Olayemi Olajide Osiyemi, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2580 Metrocentre Blvd Ste 3, West Palm Beach, FL 33407 Phone: 561-832-6770    Fax: 561-832-3292

George A Carden, M.D. Internal Medicine - Infectious Disease Medicare: May Accept Medicare Assignments Practice Location: 1411 N Flagler Dr, Suite 7900, West Palm Beach, FL 33401 Phone: 561-655-8448    Fax: 561-655-2844

David W Dodson, M.D. Internal Medicine - Infectious Disease Medicare: May Accept Medicare Assignments Practice Location: 1411 N Flagler Dr, Suite 7900, West Palm Beach, FL 33401 Phone: 561-655-8448    Fax: 561-655-2844

Jose Antonio Menajovsky, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2580 Metrocentre Blvd Ste 3, West Palm Beach, FL 33407 Phone: 561-832-6770    Fax: 561-832-3292

Lorenzo Oscar Telleria Jr., MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 5827 Corporate Way, West Palm Beach, FL 33407 Phone: 561-844-9443

News Archive

Xylem's YSI biochemistry analyzer ideal for food process applications

The 2900 Series Biochemistry Analyzers from YSI, a Xylem brand, deliver rapid, accurate biochemistry analysis and provide several data management solutions for making process and quality assurance decisions in food process applications.

PharmaMar initiates PM060184 Phase I clinical trial in patients with solid tumors

PharmaMar SA has announced the commencement of a Phase I clinical trial with PM060184 for patients with solid tumors. PM060184 is a marine-derived, synthetically-produced compound which has shown strong in vitro and in vivo antitumor activity and a favorable safety profile in preclinical toxicology studies. PM060184 is PharmaMar's sixth compound in clinical development.

Study shows obesity is related to kidney failure

Researchers at the University of California, San Francisco have determined that there is a strong relationship between being obese and developing end-stage renal disease, or kidney failure.

Researchers discover how neurons help learn new motor skills

It takes a surprisingly small cluster of brain cells deep within the cerebellum to learn how to serve a tennis ball or line up a hockey shot. Researchers at McGill University led by Kathleen Cullen from the Department of Physiology have discovered that to learn new motor skills, neurons within the cerebellum engage in elegant, virtually mathematical, computations to quickly compare expected and actual sensory feedback. They then quickly readjust, changing the strength of connections between other neurons to form new patterns in the brain in order to accomplish the task at hand.

Imaging technique reveals differences between radiation-sensitive and treatment-resistant tumors

Researchers have started pilot clinical studies in head and neck cancer patients to determine if Raman spectroscopy, a noninvasive imaging technique, can effectively spare some patients of the toxic side effects of ineffective radiation therapy.

Read more Medical News

› Verified 6 days ago